Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7

E. V. Dementyeva, V. R. Kovalenko, M. K. Zhiven, E. I. Ustyantseva, E. I. Kretov, Yu V. Vyatkin, S. M. Zakian

Research output: Contribution to journalArticlepeer-review

Abstract

Hypertrophic cardiomyopathy (HCM) is one of the most frequent cardiovascular diseases but no methods to prevent its progression have been developed. Cardiomyocytes derived from patient-specific induced pluripotent stem cells can become a platform to study pathogenesis of the disease and to search for more effective therapy methods. We generated two iPSC lines from peripheral blood mononuclear cells of an HCM patient with heterozygous p.M659I mutation in MYH7 using episomal vectors. The iPSC lines expressed pluripotency markers, demonstrated ability to spontaneously differentiate into derivatives of three germ layers, and retained the mutation.

Original languageEnglish
Article number101840
Number of pages4
JournalStem Cell Research
Volume46
DOIs
Publication statusPublished - Jul 2020

Keywords

  • PLURIPOTENT STEM-CELLS

Fingerprint

Dive into the research topics of 'Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7'. Together they form a unique fingerprint.

Cite this